RT Journal Article
SR Electronic
T1 Chimeric Antigen Receptor T-Cell Therapy: What the Neuroradiologist Needs to Know
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP 766
OP 768
DO 10.3174/ajnr.A6042
VO 40
IS 5
A1 Valand, H.A.
A1 Huda, F.
A1 Tu, R.K.
YR 2019
UL http://www.ajnr.org/content/40/5/766.abstract
AB SUMMARY: Chimeric antigen receptor T-cell therapy is an exciting and rapidly emerging “fifth pillar” treatment for hematologic cancers. Unique treatment-related toxicities and cost remain a major hindrance to its widespread application. The commonly faced challenges with this innovative therapy, its neurotoxicity, and manifestation on neuroimaging studies, are reviewed.CARchimeric antigen receptorCRScytokine release syndromeCRESCAR-T-cell–related encephalopathy syndrome